Evaluation of biomarkers in the studies of keloid tissue after laser therapy
Open Access
- 9 January 2022
- journal article
- Published by Remedium, Ltd. in Medical Council
- No. 21-2,p. 80-85
- https://doi.org/10.21518/2079-701x-2021-21-2-80-85
Abstract
In this paper, we discuss what biomarkers to choose if there is a need to describe the results of laser therapy targeting keloid skin. We elevate the known cytomarkers (Krt14, Lgals7, Krt5, Dcn, Lum, Igfbp5, Cd31, Vwf, Stambpl1, Uqcrb, Cd3 and Acta2), biomarkers of the inflammatory response (Cd45/Ptprc, Adgre1, Ly6g, Il1b, Il4, Il13, Il22, Cxcl2 и Ccl17), as well as the proteins of extracellular matrix (type I and III collagens; precursors of COL5A1 and COLA1A; FTL, COL3A1, PGLS, CNN2, ANXA2, TPSAB1, COL12A1, precursors of APCS and ALB), and their encoding genes (FGF7, BAX, CCND1, MMP3, MMP9, CXCL1, -2, -5, -6 and -12; IL8, S100A7 and IL1A), those expression and co-location may potentially change the appearance and internal structure of damaged skin. We also describe how to choose biomarkers using the results genomic studies and their limitations. Moreover, we provide examples of how different groups of gene and protein biomarkers are used in experimental biology and clinical practice. According to the previously published data, well-known biomarkers verified on animal models, depend on their biological effects, let to characterize structural changes and changes in the composition of cells represented at the site of damage before and after the treatment. In addition, the published experimental and clinical data provide an opportunity to analyze the efficiency of new experimental approaches and compare them to each other.This publication has 39 references indexed in Scilit:
- Levels of adiponectin, a marker for PPAR-gamma activity, correlate with skin fibrosis in systemic sclerosis: potential utility as a biomarker?Arthritis Research & Therapy, 2012
- A genomic biomarker signature can predict skin sensitizers using a cell-based in vitro alternative to animal testsBMC Genomics, 2011
- Measurement of matrix metalloproteinase 9-mediated Collagen type III degradation fragment as a marker of skin fibrosisBMC Dermatology, 2011
- Strategies for prevention of scars: what can we learn from fetal skin?International Journal of Dermatology, 2010
- Mechanisms of skin fibrosis in systemic sclerosisThe Journal of Dermatology, 2010
- Scleroderma-like Fibrosing DisordersRheumatic Disease Clinics of North America, 2008
- Expression profiling of endogenous secretory receptor for advanced glycation end products in human organsLaboratory Investigation, 2005
- Association of Uterine and Salpingeal Fibrosis with Chlamydial Hsp60 and Hsp10 Antigen-Specific Antibodies inChlamydia-Infected KoalasClinical and Vaccine Immunology, 2005
- Transcriptional Profiling of Epidermal Keratinocytes: Comparison of Genes Expressed in Skin, Cultured Keratinocytes, and Reconstituted Epidermis, Using Large DNA MicroarraysJournal of Investigative Dermatology, 2003
- Biomarkers of Human Skin Cells Identified Using DermArray DNA Arrays and New Bioinformatics MethodsBiochemical and Biophysical Research Communications, 2002